RESUMO
BACKGROUND: Few epidemiological studies on the correlation between phthalate exposure and elderly obesity in China are available. The purpose of the present study is to assess phthalate exposure levels and explore the connections between exposure to phthalates and obesity using a sample of Chinese community-dwelling elderly individuals. METHODS: Data were acquired from the baseline survey of the Cohort of Health of Elderly and Controllable Factors of Environment, which was established in Lu'an, Anhui province, China, from June to September in 2016. Urine samples were obtained to analyze the concentrations of seven phthalate metabolites, utilizing a high-performance liquid chromatography-tandem mass spectrometry method. General obesity was determined based on body mass index, and abdominal obesity based on waist circumference. Binary logistic regression models were utilized to analyze the associations of creatinine-corrected phthalate metabolite concentrations (categorized into quartiles) with general and abdominal obesity in elderly people. Moreover, a stratified analysis was performed to explore the difference between genders. RESULTS: Of 942 elderly individuals, 52.9% were defined as generally obese and 75.5% as abdominally obese. The detection rates of seven phthalate metabolites ranged from 90.07% to 99.80%. The highest median concentration was 44.08 µg/l (for MBP), and the lowest was 0.55 µg/l (for MEHP). The level of exposure to LMW(low-molecular-weight) PAEs is higher than that to HMW(high-molecular-weight) PAEs. After adjustment for confounding variables, we found a significant association between urinary MEOHP (mono-2-ethyl-5-oxohexyl phthalate), MEHP (mono-2-ethylhexyl phthalate), MBP (mono-n-butyl phthalate), MEP (mono-ethyl phthalate), and MMP (mono-methyl phthalate) levels and general obesity. MBP levels were also correlated with abdominal obesity. When stratified by gender, higher urinary levels of MEOHP, MBP, MEP, and MMP were associated with general obesity in males, whereas MBP and MMP levels were eminently correlated with general obesity in females. Higher urinary MBP levels were associated with increased abdominal obesity rates in males, but not in females. CONCLUSIONS: In conclusion, higher phthalate metabolite concentrations were correlated with obesity in the elderly. Moreover, a gender difference was observed in these associations.
Assuntos
Exposição Ambiental/estatística & dados numéricos , Poluentes Ambientais/urina , Obesidade/epidemiologia , Ácidos Ftálicos/urina , Idoso , Índice de Massa Corporal , China/epidemiologia , Estudos de Coortes , Exposição Ambiental/análise , Poluentes Ambientais/química , Feminino , Humanos , Masculino , Obesidade/urina , Ácidos Ftálicos/química , Fatores SexuaisRESUMO
OBJECTIVE: There is concern over the potential placental effects of prenatal phthalate exposure, and the potential adverse effects of prenatal phthalate exposure require further study; however, few data are available in humans. We investigated the associations between phthalate exposure in each trimester and both placental size and shape at birth. METHODS: We measured the urinary concentrations of phthalate metabolites among 2725 pregnant women in the Ma'anshan Birth Cohort. Before collecting urine samples from each of the three trimesters, the pregnant women were interviewed via questionnaires. Placental information was obtained from hospital records. We estimated the sex-specific associations between urinary phthalate concentrations in each trimester and both placental size and shape at birth using adjusted multiple regression. A linear mixed model was used for the repeated measures analysis with subject-specific random intercepts and slopes for gestational age at sample collection to test the effect of phthalate levels on placental size and shape and to estimate the effect sizes. RESULTS: Overall, placental breadth increased by 0.148cm (95% CI: 0.078, 0.218) with each 1 ln-concentration increase in MBP in the first trimester. The difference between placental length and breadth (length-breadth) decreased by 0.086cm (95% CI: -0.159, -0.012) and 0.149cm (95% CI: -0.221, -0.076) with each 1 ln-concentration increase in MMP and MBP, respectively, in the first trimester. In the second trimester, placental thickness increased by 0.017cm (95% CI: 0.006, 0.027), 0.020cm (95% CI: 0.004, 0.036), 0.028cm (95% CI: 0.007, 0.048), and 0.035cm (95% CI: 0.018, 0.053) with each 1 ln-concentration increase in MMP, MBP, MEOHP, and MEHHP, respectively. In the third trimester, placental thickness increased by 0.037cm (95% CI: 0.019, 0.056) and 0.019cm (95% CI: 0, 0.037) with each 1 ln-concentration increase in MBP and MEHP, respectively. Multiple linear regression for each offspring sex indicated that prenatal phthalate exposure increased placental thickness in both the first and second trimesters in males, whereas the corresponding relationship was close to null in females. Linear mixed models (LMMs) yielded similar results. CONCLUSION: Our results suggest the presence of associations between prenatal phthalate exposure and placental size and shape. Exposure to certain phthalates may cause the placenta to become thicker and more circular. Associations appeared stronger for the subsample representing male offspring than those for the subsample representing female offspring. Given the few studies on this topic, additional research is warranted.
Assuntos
Exposição Materna/efeitos adversos , Ácidos Ftálicos/efeitos adversos , Placenta/efeitos dos fármacos , Adolescente , Adulto , Estudos de Coortes , Feminino , Humanos , Recém-Nascido , Masculino , Ácidos Ftálicos/urina , Placenta/patologia , Gravidez , Adulto JovemRESUMO
Few studies have investigated the relationships between gestational phthalate exposure and maternal circulating vitamin D. In the Ma'anshan birth cohort, 3265 pregnant women were included. Each woman provided up to three urine and serum samples for measurement of phthalates and 25(OH)D and calcium, respectively. Linear mixed models were performed to analyse the association between phthalate metabolites and 25(OH)D and calcium. Stratified analyses of the relationship between phthalates and 25(OH)D by urine collection season were conducted. Finally, the post hoc lag effect of phthalate exposure on 25(OH)D was determined if longitudinal associations were significant. Some phthalate metabolites were associated with increased 25(OH)D but with decreased calcium. Furthermore, the relationship of phthalate exposure with 25(OH)D varied with urine collection season. Phthalate metabolites collected in summer and autumn were associated with an increase in 25(OH)D, while monobenzyl phthalate collected in winter and spring was inversely associated with 25(OH)D. Finally, high-molecular-weight phthalates had lag associations with 25(OH)D with a 1-trimester lag period. Low-molecular-weight phthalates exhibited lag associations with 25(OH)D with a 2-trimester lag period. In conclusion, the positive cross-sectional correlation between phthalate metabolites and 25(OH)D was partly affected by urine collection season. This study suggested that gestational phthalate exposure would have a lag association with maternal 25(OH)D levels.
Assuntos
Exposição Materna , Ácidos Ftálicos , Cálcio , Estudos Transversais , Feminino , Humanos , Ácidos Ftálicos/urina , Gravidez , Vitamina DRESUMO
Phthalates, a class of widely used endocrine-disrupting chemicals (EDCs), are toxic to various organ systems in animals and humans. Intrahepatic cholestasis of pregnancy (ICP) is a reversible liver dysfunction causing cholestasis in late pregnancy. Evidence on the associations between exposure to phthalates and ICP is still lacking. In the present study, we investigated the relationships between urinary concentrations of phthalate metabolites and the risk of ICP in a Chinese population-based birth cohort. Pregnant women participated in the Ma'anshan Birth Cohort (MABC) study in China. Seven phthalate metabolites were detected in a urine sample in early pregnancy. Chemical concentrations were grouped by quartiles, and associations with outcomes were examined using logistic regression with adjustment for urine creatinine, race, education, poverty status, smoking status, alcohol consumption, maternal age, prepregnancy body mass index (BMI), parity, twin pregnancy, and pregnancy-related liver complications. Of 3474 women recruited into the Ma'anshan Birth Cohort, 2760 met the inclusion criteria and contributed to further analysis and biomonitoring data. Elevated odds ratios (ORs) of ICP were observed in the highest quartiles of monomethyl phthalate (MMP) exposure (OR = 1.59, 95% confidence intervals (CI) = 1.01-2.51) and monobutyl phthalate (MBP) exposure (OR = 1.82, 95% CI = 1.16-2.85) in the adjusted analyses. Our findings add to the evidence that supports the role of maternal phthalate exposure in the first trimester of gestation as a risk factor for ICP.
Assuntos
Poluentes Ambientais , Ácidos Ftálicos , Complicações na Gravidez , China , Colestase Intra-Hepática , Estudos de Coortes , Feminino , Humanos , Exposição Materna , GravidezRESUMO
Phthalate has been widely used as a type of plasticiser in various consuming products in daily life. Recent studies have suggested that prenatal phthalate exposure may have adverse effects on fetal development. We aimed to identify the effects of in utero phthalate exposure on birth weight (BW). We evaluated a birth cohort comprising 3474 pregnant women and their single infants; 3103, 2975 and 2838 urine samples were collected in the first, second and third trimesters, respectively. Phthalate metabolites included monomethyl phthalate (MMP), monoethyl phthalate (MEP), mono-n-butyl phthalate (MBP), monobenzyl phthalate (MBzP), mono-(2-ethylhexyl) phthalate (MEHP), mono-(2-ethyl-5-oxohexyl) phthalate (MEHHP), and mono-(2-ethyl-5-hydroxylhexyl) phthalate (MEOHP), which were analysed in the urine by using high performance liquid chromatography-tandem mass spectrometry. Mixed linear model was used in the statistical analysis. Generally, MMP and MEP exposure during pregnancy was associated with decreased birth weight of infants (MMP, ß=-12.192, p=0.009; MEP, ß=-11.876, p=0.014). Hierarchical analysis found that MMP and MEOHP exposure was associated with decreased infants' birth weight only in low birth weight groups (MMP, ß=-42.538, p=0.005; MEOHP, ß=-63.224, p=0.008); MEHP and MEHHP exposure was associated with decreased infants' birth weight in both low birth weight group (MEHP, ß=-42.348, p=0.035; MEHHP, ß=-50.485, p=0.006) and high birth weight group (MEHP, ß=-16.580, p=0.034; MEHHP, ß=-18.009, p=0.040), MBP and MEHP exposure were associated with increased infants' birth weight in male NBW group (MBP, ß=10.438, p=0.039; MEHP, ß=13.223, p=0.017). Moreover, the effect has sex difference. The reduction of birth weight associated with MEHP and MEOHP exposure was stronger in male infants, while MMP and MEP exposure was more significant in female infants.
Assuntos
Peso ao Nascer , Exposição Materna/efeitos adversos , Ácidos Ftálicos/efeitos adversos , Plastificantes/efeitos adversos , Fatores Sexuais , Adulto , China , Estudos de Coortes , Feminino , Humanos , Recém-Nascido , Masculino , Gravidez , Adulto JovemRESUMO
A prospective cohort study of a Chinese population was conducted to investigate the relationship between prenatal phthalates exposure and maternal hemoglobin or anemia. Based on the Ma'anshan Birth Cohort study, 7 phthalate metabolites were quantified in spot pregnancy urine samples (nâ¯=â¯9263) from 3269 pregnant women during each trimester. The maternal hemoglobin concentrations were obtained from electronic medical records at the same three time points for each participant during pregnancy. Anemia was defined as a hemoglobin concentration below 110â¯g/L in pregnant women. Repeated measures and trimester-specific analyses were used to estimate the effects of phthalates exposure on maternal hemoglobin and anemia. The prevalence of anemia was 3.6%, 27.0%, and 26.5% during the first, second and third trimester, respectively. Repeated measures analysis showed that hemoglobin concentrations decreased by 0.55, 0.19, 0.57, 0.49, and 0.54â¯g/L with each 1 ln-transformed concentration increase of MBP, MBzP, MEHP, MEOHP, and MEHHP, respectively. Exposure to MMP, MBP, MEHP, MEOHP, and MEHHP increased the risk of anemia by 1.11-fold, 1.21-fold, 1.20-fold, 1.13-fold, and 1.16-fold, respectively. Trimester-specific regression models stratified by the sample collection time during pregnancy generated consistent results. This is the first study focusing on the effect of prenatal phthalate exposures on hemoglobin or anemia in pregnant Chinese women. We found that prenatal phthalates exposure not only decreased the concentrations of hemoglobin but also showed associations with the prevalence of anemia. Associations appeared stronger for the subsample representing women pregnant with a male fetus than those pregnant with a female fetus. Anemia remains a moderate public health problem in China, and effective measures should be implemented.
Assuntos
Poluentes Ambientais/urina , Hemoglobinas/análise , Ácidos Ftálicos/urina , Adolescente , Adulto , Anemia/sangue , Anemia/epidemiologia , Anemia/urina , China/epidemiologia , Feminino , Humanos , Masculino , Exposição Materna , Gravidez , Prevalência , Estudos Prospectivos , Adulto JovemRESUMO
Sulfamonomethoxine (SMM) is widely used in the veterinary field in China. Although some clinical surveys have revealed that sulfonamide antibiotics cause adverse nervous system symptoms, the related mechanisms of maternal SMM exposure on the neurobehavioral development of offspring remain unclear. Here, we investigated the effects of perinatal SMM exposure on the physiological and behavioral responses of pubertal offspring mice and the underlying mechanisms. We randomly allocated pregnant mice into the groups treated with SMM at different doses and the saline-treated groups. Maternal mice were orally administered SMM daily from gestational day 1 to postpartum day 21. On postnatal day (PND) 22, the parameters of growth, endocrine hormones, and brain amino acid composition were assessed, as well as the brain transcript levels of key genes involved in the mammalian target of rapamycin (mTOR) signaling pathway. From PND 50 to 55, a battery of behavioral tests relevant to anxiety and memory were then administered. Analysis of the results indicated that the pups, particularly the pubertal female offspring, showed anxiety-like behavior. Moreover, the pubertal offspring showed cognitive impairments and fat accumulation. Furthermore, the relative mRNA expression of genes involved in the mTOR signaling pathway in females on PND 22 was elevated, whereas the expression of N-methyl-d-aspartate receptor 2B (NR2B) was reduced. Together, the results showed that perinatal SMM exposure perturbs neuroendocrine functions, and further alters gene expression in the mTOR pathway and NR2B gene expression early in life, which may contribute to brain dysfunction in pubertal life.
Assuntos
Comportamento Animal/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Efeitos Tardios da Exposição Pré-Natal , Sulfamonometoxina/toxicidade , Serina-Treonina Quinases TOR/metabolismo , Animais , Peso Corporal/efeitos dos fármacos , Encéfalo/metabolismo , Relação Dose-Resposta a Droga , Feminino , Hormônios/sangue , Masculino , Camundongos , Camundongos Endogâmicos ICR , Gravidez , RNA Mensageiro/genética , Serina-Treonina Quinases TOR/genéticaRESUMO
Limited evidence revealed conflicting results on relationship between phthalate exposure and clinical pregnancy loss (gestational weeks >6). A prospective cohort study in Chinese pregnant women (n = 3220) was conducted to investigate the association between urinary phthalate metabolites and clinical pregnancy loss (gestational weeks 6 to 27; n = 109). Morning urine samples during gestational weeks 5 to 14 (mean 10.42) were collected to measure monomethyl phthalate (MMP), monoethyl phthalate (MEP), monobutyl phthalate (MBP), monobenzyl phthalate (MBzP), mono (2-ethylhexyl) phthalate (MEHP), mono (2-ethyl-5-oxohexyl) phthalate (MEOHP) and mono (2-ethyl-5-hydroxyhexyl) phthalate (MEHHP). The concentrations of low- and high-molecular weight phthalate metabolites (ΣLMWP <250 Da and ΣHMWP >250 Da) were calculated. Adjusted logistic regression models showed increased risks of clinical pregnancy loss in women with higher creatinine- normalized concentrations of MEP, MBP, MEOHP, MEHHP, ΣLMWP and ΣHMWP. Stratified analysis by gestational weeks (10 weeks) of miscarriage indicated positive associations of MEP, MEOHP, MEHHP and ΣHMWP with embryonic loss (during gestational weeks 6 to 10). The only association of foetal loss (during gestational weeks 11 to 27) was observed with MEHHP. Our findings suggested that Chinese women who were exposed to phthalates during early pregnancy had an increased risk of clinical pregnancy loss, especially embryonic loss.
Assuntos
Perda do Embrião/urina , Poluentes Ambientais/urina , Ácidos Ftálicos/urina , Adulto , China , Perda do Embrião/epidemiologia , Poluentes Ambientais/toxicidade , Feminino , Humanos , Ácidos Ftálicos/toxicidade , GravidezRESUMO
In utero exposure to phthalates may have adverse effects on pregnant women and their offsprings. Therefore, the exposure level of these substances among individuals, particularly among sensitive population, is of concern. The objective of the present study is to characterize urinary concentrations of phthalate metabolites at multiple time points during pregnancy in Chinese women. A total of 3455 pregnant women were included from Ma'anshan Birth Cohort in China. Spot urine samples in the morning (8:00-10:00) and questionnaires were obtained at three separate visits (approximately in 10, 26, and 34 gestational weeks). Seven phthalate metabolites from urine samples were analyzed, including monomethyl phthalate (MMP), monoethyl phthalate (MEP), monobutyl phthalate (MBP), mono benzyl phthalate (MBzP), mono-2-ethylhexyl phthalate (MEHP), mono (2-ethyl-5-oxohexyl) phthalate (MEOHP) and mono (2-ethyl-5-hydroxyhexyl) phthalate (MEHHP). Geometric means of concentrations were ranged from 0.05 to 41.0ng/mL for all the metabolites mentioned above. No individual exposure level was above the 95th percentiles for all the seven phthalates. On the three separate visits, 0.5%, 0.9% and 1.2% of the participants had coexposure to above the 75th percentiles for all metabolites. Taken these visits together, a total of 29 urine samples had concentrations above the 95th percentiles, while 3.0%-5.6% of urine levels were above 75th percentiles for at least one specific phthalate metabolite. We observed moderate intraclass correlation coefficients (ICCs) ranging from 0.44 to 0.56 for MBzP, MEHP and MEP, and lower ICCs, from 0.28 to 0.32, for MMP, MBP, MEOHP and MEHHP. Sampling season was associated with concentrations of all phthalate metabolites, showing heavier exposure was more likely to occur during summer. In summary, phthalate exposure is prevalent in Chinese pregnant women. However, throughout pregnancy coexposure to multiple phthalates at the upper percentile of exposure is infrequent. Mild to moderate temporal stability indicates that a single measurement in spot urine collected in the morning (8:00-10:00) seems not enough to describe throughout pregnancy phthalate exposure. Urinary levels vary by sampling seasons, which should be taken into consideration in future analyses.
Assuntos
Poluentes Ambientais/urina , Ácidos Ftálicos/urina , Gravidez/urina , Adulto , China , Monitoramento Ambiental , Feminino , Humanos , Estações do Ano , Inquéritos e Questionários , Adulto JovemRESUMO
A prospective cohort study of a Chinese population of mother-neonate pairs (n = 3103) was conducted to investigate the relationship between the cumulative hazard index (HI) of combined diethyl phthalate (DEP), dibutyl phthalate (DBP), dibenzyl phthalate (BBzP) and di(2-ethylhexyl) phthalate (DEHP) exposure and birth outcomes. The estimated HI for phthalates was based on phthalate metabolite concentrations in urine collected between 5th and 14th gestational weeks. The median HI values according to the European Food Safety Authority tolerable daily intake (HITDI) and U.S. Environmental Protection Agency reference dose (HIRfD) were 0.358 and 0.187, respectively. A total of 16.3% and 1.9% of the women exhibited HITDI and HIRfD exceeding the value of one, respectively. In unadjusted models, the categories (low < P25, median P25-P50, high > P75) of HITDI were associated with decreased birth weight (ß = -26.34 g, p = 0.021) and head circumference (ß = -0.09 cm, p = 0.029), whereas those for HIRfD were negatively associated with birth weight (ß = -31.74 g, p = 0.005), birth length (ß = -0.11 cm, p = 0.032), head circumference (ß = -0.13 cm, p = 0.003) and chest circumference (ß = -0.10 cm, p = 0.021) in all neonates. Adjustment for potential confounders revealed that HIRfD was inversely associated with head circumference (ß = -0.10 cm, p = 0.020). Stratification by gender indicated that HIRfD was associated with decreased birth length (ß = -0.17 cm, p = 0.041) in infant boys and HITDI was associated with decreased birth weight (ß = -33.12 g, p = 0.036) and head circumference (ß = -0.13 cm, p = 0.027) in girls. This is the first study on the cumulative risk assessment of phthalate exposures in pregnant Chinese women. We found that the HI values of multiple phthalate co-exposure were sex-specifically related to birth outcomes.
Assuntos
Poluentes Ambientais/toxicidade , Ácidos Ftálicos/toxicidade , Resultado da Gravidez , Adulto , Povo Asiático , Peso ao Nascer , Tamanho Corporal , Exposição Ambiental , Poluentes Ambientais/metabolismo , Feminino , Idade Gestacional , Humanos , Recém-Nascido , Masculino , Nível de Efeito Adverso não Observado , Ácidos Ftálicos/metabolismo , Gravidez , Estudos Prospectivos , Medição de RiscoRESUMO
Cerium incorporated MCM-48 molecular sieves have been hydrothermally synthesized using a mixed template and pH adjusting route. The samples were characterized by various physicochemical methods, including X-ray diffraction, diffuse reflectance UV-Vis spectroscopy, FTIR spectroscopy, XRF spectroscopy, and nitrogen adsorption. These results reveal that cerium is incorporated in MCM-48 and it is in the form of well-dispersed tetra-coodinated cerium ion. The proper concentration of cerium and adjusting pH can keep Ce-MCM-48 with higher specific surface area , larger unit-cell parameter, narrower pore-size distribution, and thicker pore wall than those of MCM-48. These deduce higher activity, and better selectivity, thermal stability and hydrothermal stability than those of MCM-48. The concentration of Ce incorporated in MCM-48 affects the vibration of the framewoke Si of molecular sieves.
RESUMO
Animal and human studies have suggested that phthalate alters thyroid hormone concentrations. This study investigated the associations between phthalate exposure during the first trimester and thyroid hormones in pregnant women and their newborns. Pregnant women were enrolled from the prospective Ma'anshan Birth Cohort study in China. A standard questionnaire was completed by the women at the first antenatal visit. Seven phthalate metabolites were measured in one-spot urine at enrolment (10.0 ± 2.1 gestational weeks), as were thyroid hormone levels in maternal and cord sera. Multivariable linear regression showed that 1-standard deviation (SD) increase in natural log (ln)-transformed mono(2-ethylhexyl) phthalate (MEHP) and mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) was associated with 0.163 µg/dL (p = 0.001) and 0.173 µg/dL (p = 0.001) decreases in maternal total thyroxine (TT4). Both MEHP and MEHHP were negatively associated with maternal free thyroxine (FT4; ß: -0.013, p < 0.001 and ß: -0.011, p = 0.001, respectively) and positively associated with maternal thyroid-stimulating hormone (ß: 0.101, p < 0.001; ß: 0.132, p < 0.001, respectively). An inverse association was observed between monobenzyl phthalate and maternal TT4 and FT4. A 1-SD increase in ln-transformed monoethyl phthalate was inversely associated with maternal TT4 (ß: -0.151, p = 0.002). By contrast, the concentrations of phthalate metabolites in urine were not associated with those of thyroid hormone in cord serum. Our analysis suggested that phthalate exposure during the first trimester disrupts maternal thyroid hormone levels.
Assuntos
Biotransformação , Ácidos Ftálicos/farmacologia , Primeiro Trimestre da Gravidez/metabolismo , Hormônios Tireóideos/sangue , Adulto , China , Dietilexilftalato/urina , Feminino , Humanos , Recém-Nascido , Exposição Materna , Ácidos Ftálicos/metabolismo , Ácidos Ftálicos/urina , Gravidez , Estudos Prospectivos , Tireotropina/sangue , Tiroxina/sangueRESUMO
The synchronous fluorescence, first-order and second-order-derivative synchronous fluorescence spectra of BaP in cigarette mainstream smoke were studied. It was indicated that the second-order-derivative synchronous fluorescence spectrum could decrease the disturbances of BaP homologous compounds and background of sample. Hereby the present paper introduces a new method to determine BaP in cigarette mainstream smoke by solid-phase-extraction second-order-derivative synchronous fluorescence. The detection limit is 0.2 ng x mL(-1), the average recoveries of BaP are 80.2%-86.2%, and the RSD is 2.64%-3.02%.